Day: April 3, 2024

BlueRush Receives Funding From Largest Shareholder

Written by Customer Service on April 3, 2024. Posted in Public Companies.

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) — BlueRush Inc. (“BlueRush” or the “Company“) ‎‎‎(TSXV:BTV; OTCQB:BTVRF), ‎a personalized video Software as a Service (“SaaS“) company, today announced that BlueRush Digital Media Corp., the wholly owned operating ‎subsidiary of the Company, has issued a promissory note dated April 2, 2024 for principal amount of $180,000 (the “Note”) in favour of Round 13 Founders Fund SPV, L.P. (the ‎‎“Lender”). Round 13 Capital Inc., the general partner ‎of the Lender, is also the general partner of Round 13 Capital Founders ‎Fund, L.P., which owns approximately 29% of the issued and outstanding shares of BlueRush.‎ The Note accrues interest at 10% per annum ‎for four (4) months from issuance of the Note and then at 14% per annum at all times thereafter. All amounts...

Global Technologies, LTD Closes on the Sale of Its Commercial Property in Georgia

Written by Customer Service on April 3, 2024. Posted in Public Companies.

Parsippany, NJ, April 03, 2024 (GLOBE NEWSWIRE) — Global Technologies Ltd. (OTC Pink:GTLL) (the “Company” or “Global”) a company with operations in the acquisition and redevelopment of distressed properties and customer sales management is pleased to announce that it has closed on the sale of its commercial building located in Sylvester, GA. On March 26, 2024, the Company closed on the sale of its commercial building, which was part of the Foxx Trot Tango purchase that took place in June of 2023. The net funds received by the Company will be utilized for operational expenses to help further support and advance both operating businesses: 10 Fold Services and GOe3. Fredrick K. Cutcher, CEO of Global Technologies, LTD, stated “The sale of our commercial property serves as yet another successful transaction that we have been able...

U.S. Joint Industry Committee Awards Certification to Comscore for National Currency

Written by Customer Service on April 3, 2024. Posted in Public Companies.

Comscore Recognized As a Transactable Standard Across Traditional and Cross-Platform Measurement Metrics for Both Advanced Audiences and Total Households RESTON, Va., April 03, 2024 (GLOBE NEWSWIRE) — Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting, and evaluating media across platforms, today welcomed the announcement from the U.S. Joint Industry Committee (JIC) granting it National Currency Certification as a transactable cross-platform solution. This announcement by the JIC follows Comscore’s recent accreditation by the Media Rating Council for both National and Local TV measurement. The JIC’s Measurement Subcommittee determined certification following a detailed data evaluation and scoring process. Comscore was found to be transactable across both traditional metrics (ACM/AMA) and cross-platform Exact...

Maris-Tech Receives New Order for $415,800 from an Existing Defense Industry Customer

Written by Customer Service on April 3, 2024. Posted in Public Companies.

The Company will deliver a product for defense applications based on its powerful Jupiter Nano platform Rehovot, Israel, April 03, 2024 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a B2B provider of artificial intelligence (“AI”) accelerated video solutions for edge platforms, today announced that it has received a new order for $415,800 from an existing defense industry customer, for a customized product. The solution for defense applications is based on Maris-Tech’s Jupiter Nano platform, providing advanced video streaming capabilities for real-time intelligence gathering and situational awareness. The order is expected to be delivered during 2024. “We are very pleased to receive this order for a solution similar to other products delivered to the same customer. This order further...

Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension

Written by Customer Service on April 3, 2024. Posted in Public Companies.

Meeting to discuss potential of IkT-001Pro as a disease modifying treatment for Pulmonary Arterial Hypertension BOSTON and ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease, Parkinson’s-related disorders and other diseases of the Abelson Tyrosine Kinases, today announced that the Company will meet with the Office of Cardiology, Hematology, Endocrinology and Nephrology (OCHEN) in the Division of Cardiology and Nephrology (DCN) at the U.S. Food and Drug Administration (FDA) for a Pre-IND meeting to discuss IkT-001Pro (“Pro”) as a treatment for Pulmonary Arterial Hypertension (PAH). The meeting will be held on April 5, 2024,...

Ladybug’s Acquisition of E-Commerce Platform Set to Boost Annual Revenue by $2.5 Million, Aligning with Revenue Target for 2024

Written by Customer Service on April 3, 2024. Posted in Mergers And Acquisitions.

TULSA, Okla., April 03, 2024 (GLOBE NEWSWIRE) — Ladybug Resource Group, Inc. (OTC PINK: LBRG) proudly announces, through its subsidiary Growhouse Nutraceuticals Ltd. (“Growhouse”), an initiative to broaden its digital reach in North America by acquiring the primary website of Tiny Sustainable Living Ltd. This purchase aligns strategically with Ladybug’s objective to strengthen its online footprint, projecting an anticipated increase in annual revenue of approximately $2.5 million. With a focus on acquiring unique e-commerce platforms in the health and wellness sector, the website of Tiny Sustainable Living Ltd caters to an environmentally conscious audience. Its product selection, featuring organic superfood powders, plant-based supplements, and natural wellness items, distinguishes itself through the use of organically and...

Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Written by Customer Service on April 3, 2024. Posted in Public Companies.

LONDON, April 03, 2024 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer, will participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024, at 10:15am ET / 03:15pm BST. A live audio webcast of the presentation can be accessed through the Investors section of the Company’s website at www.mereobiopharma.com/investors. An archived replay of the webcast will be available on the Company’s website for two weeks following the live event. About Mereo BioPharma Mereo BioPharma is a biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has two rare disease...

Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro

Written by Customer Service on April 3, 2024. Posted in Public Companies.

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has Therapeutic Goods Administration (TGA) clearance in Australia to market the Venus Versa Pro system. The Venus Versa Pro combines the applicator of the Venus Viva MD with the Venus Versa system which are both approved in Australia and registered in Australian Register of Therapeutic Goods (ARTG). The Venus Versa Pro offers a total skin rejuvenation experience by offering three powerful technologies: Intense Pulsed Light (IPL) with SmartPulse™, NanoFractional Radio Frequency with SmartScan™, and Venus’ proprietary (MP)2 technology. These technologies synergize to enable customers to benefit from a wide variety of treatments to...

Reunion Neuroscience Inc. Announces Upcoming Presentations at the Anxiety and Depression Association of America (ADAA) 2024 Conference

Written by Customer Service on April 3, 2024. Posted in Public Companies.

MORRISTOWN, N.J., April 03, 2024 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc., a venture backed clinical-stage biopharmaceutical company committed to pushing the boundaries of neuroscience, today announced that the clinical dataset from the Company’s Phase 1 study of its lead asset, RE104, will be presented in both a podium and poster at the Anxiety and Depression Association of America (ADAA) Conference taking place April 11-14, 2024, in Boston, MA. The presentations will highlight the Phase 1 findings on RE104, a proprietary, potential best-in-class, patented prodrug of 4-OH-DiPT, a psilocybin-like compound. In a Phase 1 study, RE104 produced a psychedelic, psychoactive state similar in intensity and quality to psilocybin, but lasting only about half the time (3-4 hours) while demonstrating a similar, favorable safety profile....

Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update

Written by Customer Service on April 3, 2024. Posted in Earnings Releases And Operating Results.

MONTREAL, April 03, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report financial results and provide a business update for its first quarter ended February 29, 2024, on Wednesday, April 10 at 8:30 a.m. ET. The call will be hosted by Paul Lévesque, President and Chief Executive Officer. Mr. Lévesque will be joined by other members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer and John Leasure, Global Commercial Officer who will be available to answer questions from participants following prepared remarks. Participants...

Day: April 3, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice